N-METHYL-N-[(1S)-1-PHENYL-2-{(3S)-3-HYDROXYPYRROLIDIN-1-YL}ETHYL]-2,2-DIPHENYLACETAMIDE

PROBLEM TO BE SOLVED: To provide a novel thermostable crystalline modified form of N-methyl-N-[(1S)-1-phenyl-2-{(3S)-3-hydroxypyrrolidin-1-yl}ethyl]-2,2-diphenylacetamide and to provide a method for isolation of the same in a new form.SOLUTION: This compound having a new modified form is produced by...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BARBER ANDREW, NEUENFELD STEFFEN, BEERES HOLGER, BESCHMANN KLAUS, STEIN INGE
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BARBER ANDREW
NEUENFELD STEFFEN
BEERES HOLGER
BESCHMANN KLAUS
STEIN INGE
description PROBLEM TO BE SOLVED: To provide a novel thermostable crystalline modified form of N-methyl-N-[(1S)-1-phenyl-2-{(3S)-3-hydroxypyrrolidin-1-yl}ethyl]-2,2-diphenylacetamide and to provide a method for isolation of the same in a new form.SOLUTION: This compound having a new modified form is produced by (a) reacting 1-[(1S)-3-hydroxypyrrolidine-1-yl]-(2S)-2-methylamino-2-phenylethane with diphenylacetyl chloride at a low temperature, especially from -5°C to 10°C with each other, in which the reaction is performed by (b) dissolving diphenylacetyl chloride dissolved in a certain solvent in the same solvent and slowly adding it to 1-[(1S)-3-hydroxypyrrolidine-1-yl]-(2S)-2-methylamino-2-phenylethane preliminarily charged in the device while keeping the temperature: and then (c) recrystallizing the resultant crude product from the hot solvent successively to the reaction.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2012246321A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2012246321A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2012246321A3</originalsourceid><addsrcrecordid>eNrjZAj30_V1DfGI9NH1043WMAzW1DXUDfBw9QMKGOlWaxgDBYx1PSJdgvwjIgMig4L8fTxdPP2AiiJ9asH6YnWNdIx0XTwhmhydXUMcfT1dXHkYWNMSc4pTeaE0N4OSm2uIs4duakF-fGpxQWJyal5qSbxXgJGBoZGRiZmxkaGjMVGKAPG_MSM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>N-METHYL-N-[(1S)-1-PHENYL-2-{(3S)-3-HYDROXYPYRROLIDIN-1-YL}ETHYL]-2,2-DIPHENYLACETAMIDE</title><source>esp@cenet</source><creator>BARBER ANDREW ; NEUENFELD STEFFEN ; BEERES HOLGER ; BESCHMANN KLAUS ; STEIN INGE</creator><creatorcontrib>BARBER ANDREW ; NEUENFELD STEFFEN ; BEERES HOLGER ; BESCHMANN KLAUS ; STEIN INGE</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a novel thermostable crystalline modified form of N-methyl-N-[(1S)-1-phenyl-2-{(3S)-3-hydroxypyrrolidin-1-yl}ethyl]-2,2-diphenylacetamide and to provide a method for isolation of the same in a new form.SOLUTION: This compound having a new modified form is produced by (a) reacting 1-[(1S)-3-hydroxypyrrolidine-1-yl]-(2S)-2-methylamino-2-phenylethane with diphenylacetyl chloride at a low temperature, especially from -5°C to 10°C with each other, in which the reaction is performed by (b) dissolving diphenylacetyl chloride dissolved in a certain solvent in the same solvent and slowly adding it to 1-[(1S)-3-hydroxypyrrolidine-1-yl]-(2S)-2-methylamino-2-phenylethane preliminarily charged in the device while keeping the temperature: and then (c) recrystallizing the resultant crude product from the hot solvent successively to the reaction.</description><language>eng</language><subject>APPARATUS THEREFOR ; CHEMISTRY ; GENERAL METHODS OF ORGANIC CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20121213&amp;DB=EPODOC&amp;CC=JP&amp;NR=2012246321A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20121213&amp;DB=EPODOC&amp;CC=JP&amp;NR=2012246321A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BARBER ANDREW</creatorcontrib><creatorcontrib>NEUENFELD STEFFEN</creatorcontrib><creatorcontrib>BEERES HOLGER</creatorcontrib><creatorcontrib>BESCHMANN KLAUS</creatorcontrib><creatorcontrib>STEIN INGE</creatorcontrib><title>N-METHYL-N-[(1S)-1-PHENYL-2-{(3S)-3-HYDROXYPYRROLIDIN-1-YL}ETHYL]-2,2-DIPHENYLACETAMIDE</title><description>PROBLEM TO BE SOLVED: To provide a novel thermostable crystalline modified form of N-methyl-N-[(1S)-1-phenyl-2-{(3S)-3-hydroxypyrrolidin-1-yl}ethyl]-2,2-diphenylacetamide and to provide a method for isolation of the same in a new form.SOLUTION: This compound having a new modified form is produced by (a) reacting 1-[(1S)-3-hydroxypyrrolidine-1-yl]-(2S)-2-methylamino-2-phenylethane with diphenylacetyl chloride at a low temperature, especially from -5°C to 10°C with each other, in which the reaction is performed by (b) dissolving diphenylacetyl chloride dissolved in a certain solvent in the same solvent and slowly adding it to 1-[(1S)-3-hydroxypyrrolidine-1-yl]-(2S)-2-methylamino-2-phenylethane preliminarily charged in the device while keeping the temperature: and then (c) recrystallizing the resultant crude product from the hot solvent successively to the reaction.</description><subject>APPARATUS THEREFOR</subject><subject>CHEMISTRY</subject><subject>GENERAL METHODS OF ORGANIC CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAj30_V1DfGI9NH1043WMAzW1DXUDfBw9QMKGOlWaxgDBYx1PSJdgvwjIgMig4L8fTxdPP2AiiJ9asH6YnWNdIx0XTwhmhydXUMcfT1dXHkYWNMSc4pTeaE0N4OSm2uIs4duakF-fGpxQWJyal5qSbxXgJGBoZGRiZmxkaGjMVGKAPG_MSM</recordid><startdate>20121213</startdate><enddate>20121213</enddate><creator>BARBER ANDREW</creator><creator>NEUENFELD STEFFEN</creator><creator>BEERES HOLGER</creator><creator>BESCHMANN KLAUS</creator><creator>STEIN INGE</creator><scope>EVB</scope></search><sort><creationdate>20121213</creationdate><title>N-METHYL-N-[(1S)-1-PHENYL-2-{(3S)-3-HYDROXYPYRROLIDIN-1-YL}ETHYL]-2,2-DIPHENYLACETAMIDE</title><author>BARBER ANDREW ; NEUENFELD STEFFEN ; BEERES HOLGER ; BESCHMANN KLAUS ; STEIN INGE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2012246321A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><topic>APPARATUS THEREFOR</topic><topic>CHEMISTRY</topic><topic>GENERAL METHODS OF ORGANIC CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BARBER ANDREW</creatorcontrib><creatorcontrib>NEUENFELD STEFFEN</creatorcontrib><creatorcontrib>BEERES HOLGER</creatorcontrib><creatorcontrib>BESCHMANN KLAUS</creatorcontrib><creatorcontrib>STEIN INGE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BARBER ANDREW</au><au>NEUENFELD STEFFEN</au><au>BEERES HOLGER</au><au>BESCHMANN KLAUS</au><au>STEIN INGE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>N-METHYL-N-[(1S)-1-PHENYL-2-{(3S)-3-HYDROXYPYRROLIDIN-1-YL}ETHYL]-2,2-DIPHENYLACETAMIDE</title><date>2012-12-13</date><risdate>2012</risdate><abstract>PROBLEM TO BE SOLVED: To provide a novel thermostable crystalline modified form of N-methyl-N-[(1S)-1-phenyl-2-{(3S)-3-hydroxypyrrolidin-1-yl}ethyl]-2,2-diphenylacetamide and to provide a method for isolation of the same in a new form.SOLUTION: This compound having a new modified form is produced by (a) reacting 1-[(1S)-3-hydroxypyrrolidine-1-yl]-(2S)-2-methylamino-2-phenylethane with diphenylacetyl chloride at a low temperature, especially from -5°C to 10°C with each other, in which the reaction is performed by (b) dissolving diphenylacetyl chloride dissolved in a certain solvent in the same solvent and slowly adding it to 1-[(1S)-3-hydroxypyrrolidine-1-yl]-(2S)-2-methylamino-2-phenylethane preliminarily charged in the device while keeping the temperature: and then (c) recrystallizing the resultant crude product from the hot solvent successively to the reaction.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JP2012246321A
source esp@cenet
subjects APPARATUS THEREFOR
CHEMISTRY
GENERAL METHODS OF ORGANIC CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title N-METHYL-N-[(1S)-1-PHENYL-2-{(3S)-3-HYDROXYPYRROLIDIN-1-YL}ETHYL]-2,2-DIPHENYLACETAMIDE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T14%3A24%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BARBER%20ANDREW&rft.date=2012-12-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2012246321A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true